Page 32 - Rhythm Technologies News Today

CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally

CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services...

SAN FRANCISCO, Dec. 26, 2023 -- iRhythm Technologies, Inc. , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced...

IRhythm Technologies, Inc. (NASDAQ:IRTC – Get Free Report) has earned a consensus recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Eight analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have covered the stock in the last year is $129.89. […]

IRhythm Technologies, Inc. (NASDAQ:IRTC – Get Free Report) has received a consensus recommendation of “Buy” from the eight brokerages that are covering the stock, MarketBeat reports. Eight analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have issued a report on the stock in the last […]

Cardiovascular digital solutions market size was valued at $84.4 billion in 2022, and is estimated to reach $154.1 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032. The cardiology digital solutions market refers to the sector within the healthcare industry that focuses on the development, implementation,...

A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)-;an irregular, fast heartbeat that is associated with stroke and heart failure.

Scripps Research scientists have developed an innovative artificial intelligence (AI) model aimed at enhancing clinicians’ ability to screen patients for atrial fibrillation (AFib), a condition characterized by an irregular, rapid heartbeat linked to stroke and heart failure.

Early detection of atrial fibrillation can reduce the risk of stroke and heart failure, but screening people for the condition has been historically challenging

<p><em>Early detection of atrial fibrillation can reduce the risk of stroke and heart failure, but screening people for the condition has been historically challenging. </em></p>